Results 81 to 90 of about 8,431 (215)

Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas

open access: yesBiomarker Insights, 2019
Intraductal papillary mucinous neoplasms (IPMNs) are cystic neoplasms with the potential for progression to pancreatic cancer. Accurate prediction of the malignant potential is challenging and a proper treatment strategy has not been well established ...
Riki Ohno   +8 more
doaj   +1 more source

The European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer: Methodological Protocol

open access: yesClinical and Public Health Guidelines, Volume 3, Issue 3, July 2026.
ABSTRACT Background Pancreatic cancer remains one of the most lethal cancers despite extensive efforts and research conducted over the past decades. To effectuate groundbreaking improvements in pancreatic cancer treatment, interdisciplinary and international collaboration is essential.
Laura C. Leeuwenburgh   +112 more
wiley   +1 more source

Primary cilia (PC) in intraductal papillary-mucinous neoplasia (IPMN).

open access: yes, 2016
A/B) Two benign and (C) one malignant IPMN without PC. (D) In stromal tissue surrounding IPMN lesions, an increased fraction of cilia carrying cells (E, Kruskal-Wallis test: p F, Kruskal-Wallis test: p p p p < 0.
Nigora Dadabaeva (3269688)   +7 more
core   +1 more source

Stakeholder Consensus Selection of Data Elements and Indicators for a Pancreatic Cancer Surgical Outcomes Registry in Australia and Aotearoa New Zealand: Modified Delphi Process

open access: yesANZ Journal of Surgery, Volume 96, Issue 7-8, Page 1969-1977, July-August 2026.
ABSTRACT Background The data elements and indicators in a clinical quality registry (CQR) contribute towards the utility of its output and should be informed by stakeholder input. In Australia and Aotearoa New Zealand (AANZ), there is no CQR for pancreatic cancer surgery. This study aimed to select data elements and registry aims with stakeholder input.
Elizabeth Lockie   +40 more
wiley   +1 more source

Clonal evolutionary analysis reveals patterns of malignant transformation in pancreatic cancer from Intraductal Papillary Mucinous IPMN Neoplasms (IPMN) [PDF]

open access: yes
Intraductal papillary mucinous neoplasms (IPMNs) are critical precursors to pancreatic ductal adenocarcinoma (PDAC), a highly lethal cancer due to late detection and rapid progression.
Wedge, David C.   +23 more
core   +1 more source

RNF43 Mutations in IPMN Cases: A Potential Prognostic Factor

open access: yes, 2020
An intraductal papillary mucinous neoplasm (IPMN) is a common pancreatic precursor lesion, and it often harbors mutations in KRAS, GNAS, and RNF43. To clarify the molecular profiles of IPMNs, we conducted mutation analysis of KRAS, GNAS, and RNF43 in 61 ...
Yan Wu   +4 more
core   +1 more source

Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology

open access: yes, 2016
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic lesions with uncertain biologic behavior. This study sought objective, accurate prediction tools, through the use of quantitative histopathological signatures of nuclear images, for ...
Patel, Charmi   +21 more
core   +1 more source

Genotypes of carboxypeptidase A1 and gamma‐glutamyltransferase 1 may be useful tools for the diagnosis and the predictor of worrisome features of intraductal papillary mucinous neoplasm in Japan

open access: yesJGH Open
Background and Aim This study aimed to clarify whether several single‐nucleotide polymorphisms (SNPs)‐related chronic pancreatitis such as carboxypeptidase A1 (CPA1), carboxypeptidase B1 (CPB1), Gamma‐glutamyltransferase 1 (GGT1), G‐protein‐coupled ...
Shuhei Agawa   +14 more
doaj   +1 more source

Percentage of BMI-1 nuclear-positive cells in IPMN lesions.

open access: yes, 2014
a) The number of BMI-1-positive cells in malignant IPMN (carcinoma in situ and invasive carcinoma) was significantly higher than that in non-malignant IPMN (adenoma and borderline atypia) (p = 0.042).
Daisuke Hashimoto (607413)   +12 more
core   +1 more source

Management and outcomes of intraductal papillary mucinous neoplasms

open access: yesBJS Open, 2019
Background This study evaluated the outcome and survival of patients with radiologically suspected intraductal papillary mucinous neoplasms (IPMNs).
J. Hipp   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy